HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 01, January 2019 – Taiwan medical tourism - Combining medical travel and tourist destination       » New breast cancer drug now available in China       » Chinese scientists make important cancer finding       » Japan's plan to revolutionise healthcare sector with tech       » GSK to buy oncology drugmaker Tesaro for US$5.1 billion       » There is hope for anticancer vaccines      
INSIDE INDUSTRY
Merck invests SGD20 million laboratory in Singapore
First GMP BioReliance biosafety testing lab in Asia Pacific offering critical testing services to bring life-changing therapies to market

Merck has opened a new SGD20 million laboratory in Singapore. The 3,800-square-meter lab is the first of its kind outside of the US and UK, and the first in Singapore.

Biologics testing is a major step in the drug development process to ensure sterility, safety and overall quality of customers’ biological drug products.

The lab will support biotech and pharma customers in Singapore and the Asia Pacific region and accelerate speed-to-market for drug therapies.

The new one-stop Singapore lab consists of three different labs:

  • M Lab Collaboration Center is designed to recreate an actual manufacturing environment, and offers non-GMP lab space for training, hands-on demonstrations and process optimisation through various stages of biopharmaceutical development and manufacturing. The flexible lab allows customers to recreate their specific processes for troubleshooting critical process issues without impacting their own production line.

  • BioReliance Biosafety Testing Service Lab is the only lab in Asia-Pacific offering lot release testing (tests product biosafety profile during bioprocessing), viral clearance testing (validate client's process capability to remove adventitious viruses) and biorepository (stores precious cell banks and provide a global network of storage facilities to mitigate risk and convenient access to customer’s cell banks). These crucial safety-testing services ensure the safe release of leading medicines to patients around the world.

  • Media Development Services Lab which offers services including customised cell culture media and feed development services for biopharma customers.

Click here for the complete issue.

NEWS CRUNCH  
news Asia is the fastest growing region for nutraceuticals
news 2018 Nobel Prize in Physiology or Medicine winners
news Vitafoods Asia expands by 40 per cent in 2018
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy